Skip Navigation

Lawsuit Over LINX Device Complications To Be Prepared for Trial in May 2028

Lawsuit Over LINX Device Complications To Be Prepared for Trial in May 2028

A federal judge has cleared the way for a lawsuit over LINX device complications to go before a jury in two years, involving a woman’s claims that the recalled implant was defectively designed and that the manufacturer knew about the risks.

The original complaint was filed by Janet Wingett in the U.S. District Court for the District of Minnesota in February. The lawsuit named Torax Medical Inc. and Ethicon Inc. as the defendants, accusing the manufacturers of selling an allegedly defectively designed LINX device without adequate warnings and failing to fully remove the implants from the market after the recall was announced.

LINX Device Injury Risks

First released by Torax in 2017, the LINX Reflux Management System consisted of a small ring of magnetic beads connected by titanium wires. The devices were designed to be implanted around the lower esophageal sphincter to prevent stomach acid from flowing back into the esophagus, as a treatment for gastroesophageal reflux disease, or GERD.

While originally marketed as safe for patients, reports began to emerge of LINX device complications where the magnetic beads had become disconnected from the titanium wires. As the reports continued to mount, the U.S. Food and Drug Administration (FDA) determined that the LINX device problems were likely the result of a manufacturing defect that could lead to the damage of nearby organs, the need for revision surgery and other adverse health effects. 

Amid the growing number of adverse events, Torax ultimately announced a LINX device recall in May 2018.

However, Wingett is one of several individuals pursuing LINX device complication lawsuits, each raising similar claims that the implant can break inside the body, leading to serious injury risks. Wingett and other plaintiffs say that the manufacturer knew, or should have known, about the defects but failed to warn doctors or patients and failed to improve the design.

LINX-Reflux-Device-Lawsuit-Lawyer
LINX-Reflux-Device-Lawsuit-Lawyer

LINX Device Trial

In a pretrial scheduling order (PDF) released last month, U.S. Magistrate Judge Elizabeth Cowan Wright instructed the parties to prepare the case for trial by May 12, 2028. She directed the parties to narrow disputed issues where possible, cooperate in good faith during discovery and keep the court informed of any developments that could affect the schedule as the litigation moves forward.

“The parties are expected to work cooperatively throughout this litigation to narrow the issues in dispute, to use reasonable, good faith and proportional efforts to preserve, request, identify and produce relevant information and resolve discovery disputes, and to keep the Court timely informed of developments in the case that could significantly affect the case management schedule.”

— U.S. Magistrate Judge Elizabeth Cowan Wright

The scheduling order sets a series of key deadlines the parties must meet in preparation for the trial, with fact discovery to be completed by July 14, 2027. Expert discovery is scheduled to be concluded by November 12, 2027, with all non-dispositive motions relating to expert discovery due by November 30 of that same year.

Judge Wright also indicated that the parties may be required to hold settlement negotiations before the trial to see if it can be resolved beforehand. If there is no resolution and the lawsuit goes before a jury as planned, the trial is expected to last only three days.

LINX Device Complications Lawsuits

Even though the LINX device was recalled in 2018, it was still for sale in some foreign markets until September 2025, raising questions as to how many additional patients will experience complications in the years to come.

Due to the seriousness of the reported problems, attorneys are reviewing LINX injury claims and pursuing compensation for those who experienced complications, including:

  • The need for revision surgery or removal of the device
  • Device breakage or mechanical failure
  • Migration of the implant
  • Organ punctures or tissue damage

Sign up for more legal news that could affect you or your family.

Irvin Jackson
Written By: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

The second Bard PowerPort bellwether trial is now scheduled to begin in August after the plaintiff in a claim originally planned for trial next month died, and her family stopped pursuing litigation.
A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkin’s lymphoma.
Federal regulators have expanded an Omnipod recall after reports that internal tubing defects may cause insulin leaks and under-delivery, potentially triggering dangerous blood sugar spikes.